You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 25 No. 1, July 1971 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Juvenile GM2 Gangliosidosis

Biochemical and Ultrastructural Studies on a New Variant of Tay-Sachs Disease

John H. Menkes, MD; John S. O'Brien, MD; Shintaro Okada, MD; Jorge Grippo, MD; John M. Andrews, MD; Pasquale A. Cancilla, MD

Arch Neurol. 1971;25(1):14-22.


Abstract

Morphological and chemical studies were performed on a cerebral biopsy in a patient with the clinical course of late infantile amaurotic idiocy. Accumulation of the Tay-Sachs ganglioside, GM2 (G5) was noted in both gray and white matter. Hexosaminidase A in serum and skin fibroblast cultures was reduced to 6.6% and 12% of total hexosaminidase activity, as contrasted with 57.3% and 49.0% in controls. On electron microscopic examination there was an accumulation of intraneuronal membranous cytoplasmic bodies, zebra bodies, other varieties of lipid bodies (including aggregates of the preceding types), and lipofuscin bodies. These findings indicate that the patient had juvenile GM2 gangliosidosis, a newly recognized GM2 ganglioside storage disease in which hexosaminidase A is partially active but apparently to an insufficient degree to prevent the slow evolution of neurological symptoms.



Author Affiliations

Los Angeles; La Jolla, Calif; Los Angeles

From the departments of pediatrics and neurology (Drs. Menkes and Grippo) and pathology (neuropathology) (Drs. Andrews and Cancilla), UCLA Center for the Health Sciences, Los Angeles; Department of Psychosocial Medicine, Brentwood Veterans Administration Hospital, Brentwood, Calif (Dr. Menkes); and the Department of Neurosciences (Drs. O'Brien and Okada), School of Medicine, University of California at San Diego, La Jolla, Calif.


Footnotes

Accepted for publication Dec 30, 1970.

Reprint requests to Department of Pediatrics, UCLA Center for the Health Sciences, Los Angeles 90024 (Dr. Menkes).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Natural History of Juvenile or Subacute GM2 Gangliosidosis: 21 New Cases and Literature Review of 134 Previously Reported
Maegawa et al.
Pediatrics 2006;118:e1550-e1562.
ABSTRACT | FULL TEXT  

MR Imaging and Proton Spectroscopy of Neuronal Injury in Late-Onset GM2 Gangliosidosis
Inglese et al.
Am. J. Neuroradiol. 2005;26:2037-2042.
ABSTRACT | FULL TEXT  

Adult (Chronic) GM2 Gangliosidosis: Atypical Spinocerebellar Degeneration in a Jewish Sibship
Rapin et al.
Arch Neurol 1976;33:120-130.
ABSTRACT  

Antenatal Diagnosis and Therapeutic Trends in Sphingolipidoses
Schneck et al.
JAMA 1974;228:615-618.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.